ESPR icon

Esperion Therapeutics

175 hedge funds and large institutions have $304M invested in Esperion Therapeutics in 2024 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 49 increasing their positions, 26 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.09M
Puts
$3.5M
Net Calls
Net Calls Change

Top Sellers

1 -$36.7M
2 -$10.6M
3 -$7.51M
4
WP
Woodline Partners
California
-$6.38M
5
Goldman Sachs
Goldman Sachs
New York
-$5.44M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.54M
27
$2.45M
28
$2.03M
29
$1.88M
30
$1.81M
31
$1.65M
32
$1.32M
33
$1.27M
34
$1.23M
35
$1.15M
36
$959K
37
$923K
38
$899K
39
$849K
40
$810K
41
$802K
42
$759K
43
$758K
44
$624K
45
$613K
46
$601K
47
$564K
48
$560K
49
$551K
50
$531K